Assessing the Effect of Vitamin D Replacement on Basal Cell Carcinoma Occurrence and Recurrence Rates in Patients with Vitamin D Deficiency
dc.contributor.author | Ince, Bilsev | |
dc.contributor.author | Yildirim, Mehmet Emin Cem | |
dc.contributor.author | Dadaci, Mehmet | |
dc.date.accessioned | 2024-02-23T13:59:59Z | |
dc.date.available | 2024-02-23T13:59:59Z | |
dc.date.issued | 2019 | |
dc.department | NEÜ | en_US |
dc.description.abstract | The study aimed to determine whether 25-OH vitamin D-3 deficiency is present in patients with diagnosed BCC, and the effect of vitamin D replacement on the rates of BCC recurrence in patients with 25-OH vitamin D-3 deficiency. In this prospective study, between 2012 and 2017, in the first stage, 25-OH vitamin D-3 levels of all patients diagnosed with BCC between 2012 and 2013 were evaluated. In the second stage between 2014 and 2015, we evaluated the 25-OH vitamin D-3 level of patients who had 25-OH vitamin D-3 level < 25 ng/mL. All the patients included in the second stage had BCC recurrence. In the third stage, the patients who were diagnosed 25-OH vitamin D-3 deficiency with BCC, between 2015 and 2017, were studied. The mean 25-OH vitamin D-3 level of the patients in the second stage was 10.12 ng/mL. Recurrence was observed in 9.64% of the patients in the second stage. The mean level of serum 25-OH vitamin D-3 in the third stage was 40.1 ng/mL, and 3.49% of these patients presented with recurrence. In all the patients as the initial diagnosis and following the 25-OH vitamin D-3 level in all the patients with BCC recurrence, maintaining 25-OH vitamin D-3 levels above 25 ng/mL can significantly reduce the recurrence rate. | en_US |
dc.identifier.doi | 10.1007/s12672-019-00365-2 | |
dc.identifier.endpage | 149 | en_US |
dc.identifier.issn | 1868-8497 | |
dc.identifier.issn | 1868-8500 | |
dc.identifier.issue | 4.Haz | en_US |
dc.identifier.pmid | 31254251 | en_US |
dc.identifier.scopus | 2-s2.0-85068131323 | en_US |
dc.identifier.startpage | 145 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12672-019-00365-2 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/11405 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000498751800002 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Hormones & Cancer | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Basal Cell Carcinoma | en_US |
dc.subject | Vitamin D | en_US |
dc.subject | Skin Cancers | en_US |
dc.subject | Vitamin D Deficiency | en_US |
dc.title | Assessing the Effect of Vitamin D Replacement on Basal Cell Carcinoma Occurrence and Recurrence Rates in Patients with Vitamin D Deficiency | en_US |
dc.type | Article | en_US |